247 Recruiting Ovarian Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Ovarian Cancer Studies
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
📍 Mt. Sinai Comprehensive Cancer Center — Miami, Florida
View Study & Checklist ➔Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
📍 City of Hope — Duarte, California
View Study & Checklist ➔REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
📍 University of Colorado Cancer Center-Anschutz — Aurora, Colorado
View Study & Checklist ➔Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
View Study & Checklist ➔Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
📍 Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔UNTOLD Ovarian Cancer Unmet Needs Survey
📍 Masonic Cancer Center — Minneapolis, Minnesota
View Study & Checklist ➔NeoVax With Nivolumab in Patients With Ovarian Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
📍 Sylvester Comprehensive Cancer Center, Univ of Miami Miller School of Medicine — Miami, Florida
View Study & Checklist ➔Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
📍 Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology — New York, New York
View Study & Checklist ➔Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
📍 Start Cal — Los Angeles, California
View Study & Checklist ➔A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
📍 Site 0107 — Phoenix, Arizona
View Study & Checklist ➔Using Aspirin to Improve Immunological Features of Ovarian Tumors
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
📍 Beth Israel Deaconess Medical Center (BIDMC) — Boston, Massachusetts
View Study & Checklist ➔Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
📍 University of New Mexico Cancer Center — Albuquerque, New Mexico
View Study & Checklist ➔Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer
📍 NorthShore University HealthSystem — Evanston, Illinois
View Study & Checklist ➔ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)
📍 Honor Health — Scottsdale, Arizona
View Study & Checklist ➔A Trial of Vigil for Participants With Ovarian Cancer
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
📍 Research Site — Duarte, California
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
📍 University of Alabama at Birmingham ( Site 0006) — Birmingham, Alabama
View Study & Checklist ➔A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
📍 Usa Health Mitchell Cancer Institute — Mobile, Alabama
View Study & Checklist ➔Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's
📍 Saskatchewan Cancer Center — Saskatoon, S
View Study & Checklist ➔Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
📍 Jennifer Rauw — Victoria, British Columbia
View Study & Checklist ➔Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
📍 O'Neal Comprehensive Cancer Center at UAB — Birmingham, Alabama
View Study & Checklist ➔Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
📍 Cedars Sinai — West Hollywood, California
View Study & Checklist ➔A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
📍 Abbotsford Centre, BC Cancer Agency — Abbotsford British Columbia, British Columbia
View Study & Checklist ➔Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
📍 University of Colorado — Aurora, Colorado
View Study & Checklist ➔Genetic Testing in African Americans
📍 Georgia Cancer Center at Augusta University — Augusta, Georgia
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
📍 UC San Diego Health - Moores Cancer Center /ID# 277574 — La Jolla, California
View Study & Checklist ➔A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
📍 Tom Baker Cancer Centre — Calgary, Alberta
View Study & Checklist ➔Autophagy Maintenance (AUTOMAIN)
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
📍 The University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Depression Treatment and Screening in Ovarian Cancer Patients
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔